619 filings
Page 8 of 31
424B4
ENTO
Entero Therapeutics Inc.
11 Oct 22
Prospectus supplement with pricing info
8:12am
EFFECT
ENTO
Entero Therapeutics Inc.
7 Oct 22
Notice of effectiveness
12:15am
S-1/A
ENTO
Entero Therapeutics Inc.
IPO registration (amended)
6 Oct 22
4:17pm
CORRESP
ENTO
Entero Therapeutics Inc.
6 Oct 22
Correspondence with SEC
12:00am
CORRESP
ENTO
Entero Therapeutics Inc.
6 Oct 22
Correspondence with SEC
12:00am
CORRESP
ENTO
Entero Therapeutics Inc.
29 Sep 22
Correspondence with SEC
12:00am
CORRESP
ENTO
Entero Therapeutics Inc.
29 Sep 22
Correspondence with SEC
12:00am
CORRESP
ENTO
Entero Therapeutics Inc.
28 Sep 22
Correspondence with SEC
12:00am
CORRESP
ENTO
Entero Therapeutics Inc.
28 Sep 22
Correspondence with SEC
12:00am
S-1/A
ENTO
Entero Therapeutics Inc.
IPO registration (amended)
22 Sep 22
8:55am
S-1
ENTO
Entero Therapeutics Inc.
IPO registration
14 Sep 22
5:14pm
8-K
ENTO
Entero Therapeutics Inc.
25 Aug 22
First Wave BioPharma, Inc. Announces Reverse Stock Split
4:32pm
10-Q
2022 Q2
ENTO
Entero Therapeutics Inc.
Quarterly report
15 Aug 22
12:00am
EFFECT
ENTO
Entero Therapeutics Inc.
5 Aug 22
Notice of effectiveness
12:15am
424B3
ENTO
Entero Therapeutics Inc.
4 Aug 22
Prospectus supplement
5:24pm
CORRESP
ENTO
Entero Therapeutics Inc.
2 Aug 22
Correspondence with SEC
12:00am
UPLOAD
ENTO
Entero Therapeutics Inc.
2 Aug 22
Letter from SEC
12:00am
8-K
ENTO
Entero Therapeutics Inc.
29 Jul 22
Entry into a Material Definitive Agreement
5:16pm
S-3
ENTO
Entero Therapeutics Inc.
Shelf registration
28 Jul 22
5:14pm
D
ENTO
Entero Therapeutics Inc.
26 Jul 22
$300K in equity / options / securities to be acquired, sold $300K, 2 investors
5:00pm